The Guide to Doing Business in China provides an introduction to selected aspects relating to investment and business operations in the People’s Republic of China under current Chinese laws and policy during the COVID pandemic, including a summary of important areas of concern to all investors in China: mergers and acquisitions, data privacy issues, antitrust and competition issues, taxation, employment, intellectual property protection, trade and import and export rules, financial services, as well as anti-bribery compliance and dispute resolution issues.
With the annual J.P. Morgan Healthcare Conference pivoting to a virtual format again in 2022, we will be hosting a lineup of virtual events and reports aligned with the industry’s biggest conference.
This series of four reports features key considerations and action points for business leaders and decision-makers in the region as they make strategic decisions, pursue growth and secure lasting success. Based on a custom survey of 800 respondents, in partnership with Acuris, this series spans four main areas of business: Supply Chains, New M&A Landscape, Digital Transformation and ESG.
Until now, any member of the public can obtain through a standard company search information regarding the residential addresses and personal identification numbers of directors and company secretaries of Hong Kong-registered companies on the register of the Companies Registry. In light of the growing concern about the availability and use of personal information, an inspection regime to protect such personal information was included in the new Companies Ordinance (Cap 622).
This report, the fourth in our Asia Pacific Business Renewal Series, explores how businesses are now fortifying their ESG efforts and pivoting from strategy to action.
This report, the third in our Asia Pacific Business Renewal Series, explores how digital transformation (DX) has become a driving force in business decision making, and how it will shape the business landscape over the decade to come. As companies respond to shifting demand patterns and propel their DX agenda, the conversation turns to areas such as managing emerging risks, creating value from new technologies and aligning DX efforts with business renewal.
As the world prepares for the rollout of the COVID-19 vaccine, manufacturers, governments, and clients in the logistics sector are looking into various structures and arrangements that will help bring the vaccine to the public as soon as possible.
Our Primer focuses on key legal issues and high-level considerations on topics such as the procurement framework, regulatory approvals, and contractual stipulations relating to the supply and distribution of the COVID-19 vaccine across 14 Asia Pacific jurisdictions.
On 19 December 2020, the National Development and Reform Commission (NDRC) and the Ministry of Commerce (MOFCOM) jointly issued the Measures for Security Review of Foreign Investment (New Measures) (the official Chinese text is available here; and an unofficial translation is available here). The New Measures, effective from 18 January 2021, represent…
Click to read Digital healthcare, a globally booming market, has been catalyzed by the events of COVID-19. In Asia Pacific, in particular, a rapidly expanding population, an empowered and tech-savvy middle class and physician shortage has created the perfect conditions for digital health innovation. A new era of digital healthcare…
Partners Tracy Wut and Derek Poon were featured in Private Equity International’s Keynote Interview, entitled “China’s rebound creates domestic PE opportunities.” In this interview they reflected on the impact of COVID-19 on PE firms and portfolio companies and its ramifications on deal activity in China. They also discussed the effects…